China's MOH Solicits Feedback On Revised Standards For Outpatient Departments And Clinics
This article was originally published in PharmAsia News
Executive Summary
China's Ministry of Health has circulated its revised draft on standards for outpatient departments and clinics among medical administration departments of provincial health bureaus for feedback. The document states that outpatient departments: should not provide technically complicated, difficult and high risk medical care; should not conduct general anesthesia surgery; and can perform epidural anesthesia operations only upon registered organizations' approval. Clinics can only diagnose and treat common ailments as well as conduct surgery under local anesthesia. Compared with the 1994 edition, the latest revision removes sections on outpatient plastic surgery as well as plastic surgery, medical beauty and psychiatry by clinics. In addition, MOH for the first time specifies that outpatient departments and clinics should not set up inpatient beds or obstetric tables, but can have fewer than 10 beds for patient observation. (Click here for more - Chinese Language)
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.